HAE
HAE
US4050241003
Haemonetics Corporation
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2026 2025 Change %
Total Revenue 1.334.027.000 1.360.824.000
2.0%
Cost of Revenue 546.441.000 611.866.000
10.7%
Gross Profit 787.586.000 748.958.000
5.2%
546.185.000 547.772.000
0.3%
Operating Income 241.401.000 201.186.000
20.0%
Pretax Income 128.030.000 212.071.000
39.6%
Net Income Common Stockholders 97.308.000 167.679.000
42.0%
-- --
--
-- --
--
ende